In addition to the development and evaluation of such new test methods and molecular biological assay systems, aspects of external quality control and diagnostic test standardization are of outstanding importance throughout our scientific projects.
Established projects at our institute include the organization and analysis of proficiency testing programs in bacteriologic infection serology in medical laboratories and are funded by the German Society for Hygiene and Microbiology (DGHM) and the Society for Promotion of Quality Assurance in Medical Laboratories e. V. (INSTAND e.V., Düsseldorf, Germany).
Another project called GILEAD (German Investigation on Lyme Borreliosis & Syphilis: Evaluation of Therapeutic And Diagnostic Cost) funded by INSTAND e.V., Düsseldorf, is an analytical start up focused on a better characterization of the burden of disease and the medical costs of Lyme borreliosis and syphilis diagnostics in Germany.
In a further approach called “Borreliosis Care” funded by the Bundesministerium für Bildung und Forschung (BMBF), Bonn (FKZ: 01GY1137), in depth analysis of sickness fund data are provided by German health insurance companies to learn more about the actual economic situation and the epidemiological background (incidence, prevalence, diagnostics, treatment, medical cost etc.) of health care utilization related to Lyme borreliosis in Germany. Our results have been published in peer reviewed journals.
Das Zentralinstitut für Labormedizin, Mikrobiologie und Krankenhaushygiene publiziert regelmäßig Forschungsergebnisse in namhaften nationalen und internationalen Fachzeitschriften.
The Institute for Laboratory Medicine, Microbiology and Hospital Hygiene is publishing research results on a regular basis in renowned national and international scientific journals.